ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,782.98
2.37%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.19%
Brent Oil
83.76
0.67%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cyclacel Pharmaceuticals Inc (CYCC)

  7. Cyclacel Pharmaceuticals Inc (CYCC) ニュース

CYCC

Cyclacel Pharmaceuticals (CYCC)

Cyclacel Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CYCC
日付受信時刻ニュースソース見出しコード企業名
2024/05/1505 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/05/0822 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/05/0305 : 30GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ RulesNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/05/0102 : 51AllPennyStocks.com$8 Million Private Placement Announcement Sends Biotech FlyingNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/04/3020 : 00GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/04/0122 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for CancerNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/03/2005 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/03/1920 : 27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/03/1405 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/03/0723 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/03/0623 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax CreditNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/02/2023 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor ConferenceNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2024/01/3023 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical OfficerNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/12/1823 : 00GlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP DeletionsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/12/1306 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Reverse Stock SplitNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/11/3023 : 15GlobeNewswire Inc.Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SECNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/11/2907 : 15GlobeNewswire Inc.Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-QNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/11/0723 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/08/1005 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/08/0322 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/06/1505 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/1206 : 16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/1205 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/1205 : 05GlobeNewswire Inc.Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/0505 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/0422 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/05/0322 : 15GlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax CreditNASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/03/1319 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/03/1006 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
2023/03/0907 : 03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CYCC

最近閲覧した銘柄

USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
FX
USDEUR
US Dollar vs Euro
AMEX
XLF
Financial Select Sector
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有